UN

Upender Namani

Active Director Director DIN 08684672
DIN 08684672 First appointment Jan 2020 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2020
Shareholding value •••• Premium profile

About Upender Namani

Data last updated:

Upender Namani is a Director at Vsk Life Sciences Private Limited (since 2020). The company operates in Trading. Vsk Life Sciences Private Limited reported revenue of ₹80.8 Lakh (FY 2025).

DIN 08684672
Primary Designation Director
Industry Trading
First Appointment 30 Jan 2020
Oldest Company Age 6 yrs
Largest company Vsk Life Sciences Private Limited · ₹80.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vsk Life Sciences Private Limited U51909TG2020PTC138851
Director30 Jan 20202020₹80.8 Lakh (FY 2025)Active

Board colleagues of Upender Namani

Directorship timeline

Open interactive timeline →
Vsk Life Sciences Private Limited
Premium access

Shareholding and investment profile for Upender Namani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Upender Namani

Upender Namani currently holds 1 directorship: Vsk Life Sciences Private Limited (Director, since 30 Jan 2020, revenue ₹80.8 Lakh (FY 2025)).

Upender Namani was first appointed on 30 Jan 2020 as Director at Vsk Life Sciences Private Limited.

The current boards of Upender Namani's companies include Karunakar Jella (Vsk Life Sciences Private Limited), Sudha Kema (Vsk Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available